Biography
Dr. Jiang Li is currently a Research Assistant Professor at the Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology. He received his Ph.D. in Biomedical Sciences from the City University of Hong Kong in 2024, with a visiting scholarship at the City of Hope National Medical Center in the United States. His research focuses on the core framework of artificial intelligence and multi-omics big data, conducting systematic studies on cancer precision subtyping, non-coding RNA regulatory mechanisms, and clinical translation. He is dedicated to developing bioinformatics tools and pan-cancer databases for tumor diagnosis and prognosis. He has published 11 SCI and conference papers as first author or corresponding author (including co-authorship) in journals such as Nucleic Acids Research (2020, 2026), iScience (2025), Clinical & Experimental Allergy (2026), International Immunopharmacology (2025), Computational and Structural Biotechnology Journal (2022, 2024), and STAR Protocols (2025). He also serves as a reviewer for MedComm and other journals.
Education
-
2020.9 – 2024.8
Ph.D., Cancer Bioinformatics
Supervisor: Prof. Xin Wang (Department of Surgery, CUHK)
Prof. Rebecca Y. CHIN (Department of Biomedical Sciences, CityUHK)
-
2022.7 – 2023.1
Visiting Scholar, Global Scholar Program
Supervisor: Prof. Ajay Goel (Chair & Distinguished Professor)
-
2017.9 – 2020.7
M.Sc., Bioinformatics
Supervisor: Prof. Hong-Yu Zhang
-
2018.7 – 2018.8
Visiting Student, Summer Workshop Program
-
2013.9 – 2017.7
B.Sc., Biological Sciences
Research Experience
-
2026.04 – Present
Research Assistant Professor
-
2024.11 – 2026.04
Assistant Research Fellow
Publications
Circulating Piwi-interacting RNAs Associate with Childhood Asthma ICS Response with Vitamin D Effect Modification.
Clinical & Experimental Allergy, 2026
PCsRNAdb: a comprehensive resource of small noncoding RNAs across cancers.
Nucleic Acids Research, 2026; 54(D1): D1545–D1555
Deciphering aging-associated prognosis and heterogeneity in gastric cancer through a machine learning-driven approach.
iScience, 2025; 28: 112316
Leveraging miRNA-mediated expression profiles to predict prognosis and identify distinct molecular subtypes in ovarian cancer: a multi-cohort study.
International Immunopharmacology, 2025; 150: 114303
Protocol for tumor prognostic prediction, molecular stratification, and target discovery using a machine learning-driven approach.
STAR Protocols, 2025; 6(4): 104130
Expression pattern of cancer-associated cellular senescence genes in clear cell renal cell carcinoma distinguishes tumor subclasses with clinical implications.
Scientific Reports, 2025; 15(1): 442
Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
Thorax, 2025; 80(11): 788–795
GCclassifier: An R package for the prediction of molecular subtypes of gastric cancer.
Computational and Structural Biotechnology Journal, 2024; 23: 752–758
Identification of subtype-specific master regulatory long non-coding RNAs of gastric cancer through a network-based approach.
2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Istanbul, Turkiye. 2023; pp. 2777–2782
Ginseng mediates its anti-cancer activity by inhibiting the expression of DNMTs and reactivating methylation-silenced genes in colorectal cancer.
Carcinogenesis, 2023; 44: 394–403
Integrative network analysis reveals subtype-specific long non-coding RNA regulatory mechanisms in head and neck squamous cell carcinoma.
Computational and Structural Biotechnology Journal, 2022; 21: 535–549
Akt3 promotes cancer stemness in triple-negative breast cancer through YB1-Snail/Slug signaling axis.
Genes & Diseases, 2022; 10: 301–306
ncRNA-eQTL: a database to systematically evaluate the effects of SNPs on non-coding RNA expression across cancer types.
Nucleic Acids Research, 2020; 48(D1): D956–D963
A Machine Learning Method for Drug Combination Prediction.
Frontiers in Genetics, 2020; 11: 1000
Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease Associated Genes as Drug Candidates.
Frontiers in Genetics, 2019; 10: 474
Patents & Software Copyrights
A Drug Activity Prediction Method and Its Application
Invention Patent, ZL201710769899.7, Patentee (Rank 4/7), CNIPA
GCclassifier: R-based Gastric Cancer Molecular Subtype Prediction Platform
2026SR0082562, Copyright Holder (Rank 1/3), NCAC
COMPSRA: Java-based miRNA Data Analysis Platform
2025SR2014194, Copyright Holder (Rank 3/3), NCAC
Deep-eccScan: Deep Learning-based Extrachromosomal Circular DNA Detection Software
2025SR2477308, Copyright Holder (Rank 3/3), NCAC